Literature DB >> 28738533

MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.

Xiao-Yan Wang1, Xing-Yu Chen1, Jun Li2, Hong-Ying Zhang3, Juan Liu4, Le-Dong Sun4.   

Abstract

The main aim of this study is to investigate the underlying relationship shared between microRNA-200a (miR-200a) and its link to concentrations of Th17 and Treg cells, mRNA expressions of their specific transcription factors retinoic acid-related orphan receptor γt (RORγt) and head box protein 3 (FOXP3) and relevant cytokines in patients with psoriasis vulgaris (PV). A total of 189 patients previously diagnosed with PV were selected as the experimental group, whilst 109 healthy individuals as the control group. According to the psoriasis area and severity index (PASI), subjects in the experimental group were assigned into the severe group (95 cases) and the moderate group (94 cases). CD4+ T and Th17/Treg cells were extracted. MiR-200a expression and RORγt and FoxP3 mRNA expressions were detected by qRT-PCR. Concentrations of Th17 and Treg cells were measured via flow cytometry. ELISA was conducted for serum IL-17, IL-23 and TGF-β levels. Correlation analysis was completed in accordance with the Pearson method. Compared with the moderate group, higher miR-200a expression, RORγt mRNA expression, percentage of Th17, Th17/Treg ratio and levels of IL-17 and IL-23 exhibited in the severe group, whilst FoxP3 mRNA expression and, percentage of Treg as well as TGF-β were lower. A same trend displayed when comparing the moderate group to the control group. We found that miR-200a expression, percentage of Th17, Th17/Treg ratio, IL-17 and IL-23 levels and RORγt mRNA expression are positively correlated with PASI grade, while the percentage of Treg, TGF-β level and FoxP3 mRNA expression are negatively correlated with PASI grade. The results also displayed that the percentage of Th17, Th17/Treg ratio, IL-17 and IL-23 levels and RORγt mRNA expression are positively correlated with miR-200a expression, while the percentage seen in Treg and TGF-βand FoxP3 mRNA expression are negatively correlated with miR-200a expression. Our results provided a strong evidence that up-regulation of microRNA-200a in CD4+ T cells may induce immune dysfunction through Th17/Treg cells and relevant cytokines in PV patients.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CD4(+) T cell; Cytokines; IL-17; IL-23; MicroRNA-200a; Psoriasis vulgaris; Retinoic acid-related orphan receptor γt; TGF-β; Th17 cell; Treg cell

Mesh:

Substances:

Year:  2017        PMID: 28738533     DOI: 10.1016/j.biopha.2017.06.055

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

Review 1.  MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease.

Authors:  Cuilian Liu; Haoran Yang; Weiyun Shi; Ting Wang; Qingguo Ruan
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

2.  Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies.

Authors:  Ting-Ting Zhang; Junli Ma; Kenneth R Durbin; Timothy Montavon; Susan E Lacy; Gary J Jenkins; Stella Doktor; J Cory Kalvass
Journal:  AAPS J       Date:  2019-06-27       Impact factor: 4.009

Review 3.  Pipeline Impact of Radiolabeled Compounds in Drug Discovery and Development.

Authors:  Srirajan Vaidyanathan; Aimee Reed
Journal:  ACS Med Chem Lett       Date:  2022-09-16       Impact factor: 4.632

Review 4.  miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes.

Authors:  Martin G Scherm; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2020-07-28       Impact factor: 4.810

Review 5.  Cytokine Targeting by miRNAs in Autoimmune Diseases.

Authors:  Valentina Salvi; Veronica Gianello; Laura Tiberio; Silvano Sozzani; Daniela Bosisio
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 6.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03

7.  Is microRNA 1910-3p (miR-1910-3p) a really distinctive marker for psoriasis?

Authors:  Melek Karabacak; İjlal Erturan; Kuyaş Hekimler Öztürk; Havva Hilal Ayvaz; Selma Korkmaz; Mehmet Yıldırım; Hikmet Orhan
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

Review 8.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

9.  Expression profiling of peripheral blood miRNA using RNAseq technology in dairy cows with Escherichia coli-induced mastitis.

Authors:  Zhuo-Ma Luoreng; Xing-Ping Wang; Chu-Gang Mei; Lin-Sen Zan
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

Review 10.  Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells.

Authors:  Rui Lai; Dehai Xian; Xia Xiong; Lingyu Yang; Jing Song; Jianqiao Zhong
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.